Biote Corp (BTMD)
5.75
-0.09
(-1.54%)
USD |
NASDAQ |
May 17, 16:00
5.86
+0.11
(+1.91%)
After-Hours: 20:00
Biote Cash from Operations (Quarterly): 7.372M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.372M |
| December 31, 2023 | 6.956M |
| September 30, 2023 | 0.16M |
| June 30, 2023 | 6.775M |
| March 31, 2023 | 12.99M |
| Date | Value |
|---|---|
| December 31, 2022 | 6.051M |
| September 30, 2022 | 6.393M |
| June 30, 2022 | -28.57M |
| March 31, 2022 | 6.969M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.57M
Minimum
Jun 2022
12.99M
Maximum
Mar 2023
2.789M
Average
6.775M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Teladoc Health Inc | 8.92M |
| American Shared Hospital Services | -3.06M |
| Novo Integrated Sciences Inc | -1.714M |
| Astrana Health Inc | 5.977M |
| Cryo-Cell International Inc | -0.3569M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -12.18M |
| Cash from Financing (Quarterly) | -5.409M |
| Free Cash Flow | 17.88M |
| Free Cash Flow Per Share (Quarterly) | 0.1825 |
| Free Cash Flow to Equity (Quarterly) | 7.678M |
| Free Cash Flow to Firm (Quarterly) | 9.220M |
| Free Cash Flow Yield | 10.32% |